Voya Investment Management LLC Has $7.41 Million Stake in Option Care Health, Inc. (NASDAQ:OPCH)

Voya Investment Management LLC cut its holdings in Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 64.7% during the fourth quarter, according to its most recent disclosure with the Securities & Exchange Commission. The fund owned 319,337 shares of the company's stock after selling 584,198 shares during the period. Voya Investment Management LLC owned about 0.19% of Option Care Health worth $7,409,000 at the end of the most recent quarter.

A number of other institutional investors have also made changes to their positions in the business. Wellington Management Group LLP grew its position in shares of Option Care Health by 84.6% in the 4th quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company's stock valued at $425,143,000 after acquiring an additional 8,400,208 shares during the period. Norges Bank bought a new position in Option Care Health during the fourth quarter worth about $60,219,000. Dimensional Fund Advisors LP increased its position in Option Care Health by 17.4% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,988,051 shares of the company's stock worth $92,518,000 after buying an additional 591,042 shares during the last quarter. Victory Capital Management Inc. raised its stake in Option Care Health by 31.1% in the fourth quarter. Victory Capital Management Inc. now owns 2,125,433 shares of the company's stock valued at $49,310,000 after buying an additional 503,840 shares during the period. Finally, Magnetar Financial LLC lifted its position in shares of Option Care Health by 23.1% in the fourth quarter. Magnetar Financial LLC now owns 2,350,598 shares of the company's stock valued at $54,534,000 after buying an additional 441,265 shares during the last quarter. Institutional investors own 98.05% of the company's stock.

Wall Street Analyst Weigh In

A number of research analysts recently weighed in on the company. Barrington Research reissued an "outperform" rating and set a $38.00 target price on shares of Option Care Health in a report on Wednesday. JPMorgan Chase & Co. raised their target price on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research note on Thursday, March 6th. JMP Securities reissued a "market outperform" rating and issued a $36.00 price target on shares of Option Care Health in a report on Tuesday, April 22nd. UBS Group upgraded shares of Option Care Health from a "neutral" rating to a "buy" rating and raised their price objective for the stock from $38.00 to $40.00 in a research report on Wednesday. Finally, Bank of America raised Option Care Health from a "neutral" rating to a "buy" rating and upped their target price for the company from $26.00 to $33.00 in a research report on Monday, January 13th. One investment analyst has rated the stock with a hold rating and seven have issued a buy rating to the company. According to MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus price target of $35.50.

Option Care Health Price Performance

Option Care Health stock traded up $0.78 during mid-day trading on Friday, reaching $32.95. 3,358,100 shares of the company were exchanged, compared to its average volume of 1,827,653. The company has a fifty day simple moving average of $33.35 and a 200-day simple moving average of $28.85. The firm has a market cap of $5.41 billion, a PE ratio of 27.69, a PEG ratio of 2.30 and a beta of 1.07. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.73 and a quick ratio of 1.32. Option Care Health, Inc. has a 12 month low of $21.39 and a 12 month high of $35.53.

Option Care Health (NASDAQ:OPCH - Get Free Report) last posted its quarterly earnings data on Tuesday, April 29th. The company reported $0.40 earnings per share for the quarter, topping the consensus estimate of $0.36 by $0.04. Option Care Health had a net margin of 4.37% and a return on equity of 15.30%. The business had revenue of $1.33 billion during the quarter, compared to analysts' expectations of $1.26 billion. During the same quarter in the prior year, the business posted $0.26 earnings per share. Option Care Health's revenue was up 16.3% compared to the same quarter last year. As a group, equities research analysts expect that Option Care Health, Inc. will post 1.22 earnings per share for the current fiscal year.

Insider Activity at Option Care Health

In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the company's stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the transaction, the insider now directly owns 44,974 shares in the company, valued at approximately $1,495,835.24. This represents a 40.80 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. 0.64% of the stock is currently owned by insiders.

Option Care Health Company Profile

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.